Swiss All Share Index
17.244,44
PKT
-152,12
PKT
-0,87
%
Werbung
Analysen zu Swiss All Share Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 30.06.05 | ABB (Asea Brown Boveri) neutral | Bank Sarasin & Cie | |
| 30.06.05 | ABB (Asea Brown Boveri) kaufen | Helaba Trust | |
| 24.06.05 | Zurich Insurance | DZ-Bank | |
| 24.06.05 | Swiss Life buy | Smith Barney Citigroup | |
| 23.06.05 | Swatch (I) kaufen | National-Bank AG | |
| 23.06.05 | Richemont kaufen | National-Bank AG | |
| 23.06.05 | Nestlé | Zürcher Kantonalbank | |
| 23.06.05 | Holcim | Focus Money | |
| 23.06.05 | Lonza underweight | Morgan Stanley | |
| 23.06.05 | Baloise | Wirtschaftswoche | |
| 22.06.05 | ABB (Asea Brown Boveri) kaufen | Helaba Trust | |
| 22.06.05 | Novartis neutral | Bank Sarasin & Cie | |
| 20.06.05 | Logitech kaufen | Die Actien-Börse | |
| 17.06.05 | Zurich Insurance | DZ-Bank | |
| 21.06.05 | Novartis buy | Jyske Bank | |
| 17.06.05 | Novartis reduce | UBS | |
| 16.06.05 | UBS | Weberbank | |
| 16.06.05 | Novartis neutral | Robert W. Baird | |
| 16.06.05 | Richemont halten | Hamburger Sparkasse | |
| 16.06.05 | Novartis | Weberbank | |
| 16.06.05 | Nestlé | Weberbank | |
| 16.06.05 | Richemont kaufen | Focus Money | |
| 16.06.05 | Richemont | Zürcher Kantonalbank | |
| 17.06.05 | Logitech neutral | Bank Sarasin & Cie | |
| 17.06.05 | ABB (Asea Brown Boveri) kaufen | National-Bank AG | |
| 10.06.05 | Zurich Insurance | DZ-Bank | |
| 10.06.05 | Richemont overweight | JP Morgan | |
| 10.06.05 | Holcim halten | Helaba Trust | |
| 10.06.05 | Novartis halten | Fuchsbriefe | |
| 10.06.05 | Swiss Life Marketperformer | LB Rheinland-Pfalz | |
| 09.06.05 | BB Biotech | Kayenburg | |
| 08.06.05 | Novartis neutral | HypoVereinsbank | |
| 08.06.05 | Clariant | Aktienservice Research | |
| 07.06.05 | Richemont verkaufen | Helaba Trust | |
| 07.06.05 | Novartis neutral | Bank Sarasin & Cie | |
| 06.06.05 | Sulzer | Euro am Sonntag | |
| 06.06.05 | Sonova | Die Actien-Börse | |
| 03.06.05 | Zurich Insurance | DZ-Bank | |
| 06.06.05 | Novartis buy | Merrill Lynch | |
| 03.06.05 | Novartis | Der Aktionärsbrief |